Jack Kaye
Vermögen: 807 276 $ am 31.05.2026
Vermögen: 807 276 $ am 31.05.2026
Jack L.
Kaye is currently an Independent Director at Dyadic International, Inc. since 2015, an Independent Non-Executive Director at uniQure NV since 2016, a Director at DiaCarta, Inc. since 2022, and a Director at Tda Industries, Inc. since 2024.
Former positions include Independent Director at Keryx Biopharmaceuticals, Inc. from 2011 to 2016, Director at Balboa Biosciences, Inc., Independent Director at Tongli Pharmaceuticals (USA), Inc., and Partner at Deloitte LLP (New York) from 1978 to 2006.
Education includes undergraduate studies at Baruch College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UNIQURE N.V. 0,04 % | 17.06.2026 | 25.996 ( 0,04 % ) | 741 666 $ | 31.05.2026 |
| 24.04.2026 | 81.201 ( 0,22 % ) | 65 610 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 01.05.2015 |
| UNIQURE N.V. | Direktor/Vorstandsmitglied | 15.06.2016 |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company | Direktor/Vorstandsmitglied | 07.04.2022 |
Tda Industries, Inc.
Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials | Direktor/Vorstandsmitglied | 01.02.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Direktor/Vorstandsmitglied | 25.05.2016 |
| TONGLI PHARMACEUTICALS (USA), INC. | Direktor/Vorstandsmitglied | 19.06.2009 |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, tax and financial advisory services | Corporate Officer/Principal | 01.05.2006 |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Tda Industries, Inc.
Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials | Distribution Services |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Dyadic International, Inc.
Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products | Health Services |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, tax and financial advisory services | Commercial Services |
Baruch College
Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Tongli Pharmaceuticals (USA), Inc.
Tongli Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical and health care products | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen